ESC Premium Access

A Cluster Randomized Trial of Objective Risk Assessment Versus Standard Care for Acute Coronary Syndromes: The Australian GRACE Risk score Intervention Study

Congress Presentation

About the speaker

Professor David Brieger

ANZAC Research Institute, Sydney (Australia)
1 presentation
0 follower

3 more presentations in this session

Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes

Speaker: Doctor K. Koskinas (Bern, CH)


COMBinAtion Therapy with remote ischemic conditioning and exenatide in Myocardial Infarction. Primary results of The COMBAT-MI trial

Speaker: Doctor I. Otaegui Irurueta (Barcelona, ES)


Randomised comparison of clopidogrel versus ticagrelor or prasugrel in patients of 70 years or older with non-ST-elevation acute coronary syndrome - POPular AGE

Speaker: Miss M. Gimbel (Nieuwegein, NL)


Access the full session

Late Breaking Science in Acute Coronary Syndromes 1

Speakers: Professor D. Brieger, Doctor K. Koskinas, Doctor I. Otaegui Irurueta, Miss M. Gimbel

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb